Literature DB >> 25542811

The effect of genetic polymorphisms of TLR2 and TLR4 in Turkish patients with coronary artery disease.

Mehmet Guven1, Ziya Ismailoglu2, Bahadir Batar3, Selin Unal3, Ilhan Onaran3, Bilgehan Karadag2, Zeki Ongen2.   

Abstract

Coronary artery disease (CAD), being a multifactorial disease process, has been suggested to be associated by the interaction of both environmental and genetic risk factors. Toll-like receptors (TLRs) are related to the receptors of the innate immune system which serves as the recognition of the conserved pathogen motifs and the activation of the signals that stimulate inflammatory genes. In this study, we investigated the relationship between the polymorphisms in the TLR2-Arg753Gly, TLR4-Asp299Gly and Thr399Ile gene and CAD. The study population consisted of 300 patients (149 men, 151 women) with angiographically documented CAD. The polymorphisms were genotyped by real time PCR. No association between TLR2-Arg677Trp or TLR4-Asp299Gly and -Thr399Ile gene polymorphisms and the presence or the severity of CAD was observed. On the other hand, the TLR2-Arg753Arg genotype seemed to have a protective effect against development of CAD (OR=0.17; 95% CI=0.04-0.83). Our findings suggest that TLR2-Arg753Gly polymorphism is associated with CAD susceptibility in Turkish patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease; Polymorphism; TLR2; TLR4; Toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 25542811     DOI: 10.1016/j.gene.2014.12.047

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

Review 1.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

2.  Study on the association between IL-1β, IL-8 and IL-10 gene polymorphisms and risk of coronary artery disease.

Authors:  Baojun Ren; Qiang She
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Novel perspectives on non-canonical inflammasome activation.

Authors:  Catherine Emma Diamond; Hanif Javanmard Khameneh; David Brough; Alessandra Mortellaro
Journal:  Immunotargets Ther       Date:  2015-07-24

4.  TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?

Authors:  Maria Kalliopi Konstantinidou; Nikos Goutas; Dimitrios Vlachodimitropoulos; Antigoni Chaidaroglou; Demetrios Stefanou; Nikoleta Poumpouridou; Renata Mastorakou; Maria Gazouli; Dimitrios Kyparissopoulos; Chara Spiliopoulou
Journal:  J Cardiovasc Dev Dis       Date:  2016-03-10

5.  Association between Toll-like receptor 4 Asp299Gly polymorphism and coronary heart disease susceptibility.

Authors:  B W Wu; J Zhu; H M Shi; B Jin; Z C Wen
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

6.  Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population.

Authors:  Anton G Kutikhin; Anastasia V Ponasenko; Maria V Khutornaya; Arseniy E Yuzhalin; Irina I Zhidkova; Ramil R Salakhov; Alexey S Golovkin; Olga L Barbarash; Leonid S Barbarash
Journal:  Meta Gene       Date:  2016-04-19

7.  TLR4 Asp299Gly (rs4986790) polymorphism and coronary artery disease: a meta-analysis.

Authors:  Rui Chen; Ning Gu; Ying Gao; Wei Cen
Journal:  PeerJ       Date:  2015-11-26       Impact factor: 2.984

8.  Association of chronic inflammation and accelerated atherosclerosis among an indigenous black population with chronic kidney disease.

Authors:  Muzamil Olamide Hassan; Therese Dix-Peek; Raquel Duarte; Caroline Dickens; Sagren Naidoo; Ahmed Vachiat; Sacha Grinter; Pravin Manga; Saraladevi Naicker
Journal:  PLoS One       Date:  2020-07-10       Impact factor: 3.240

9.  Polymorphism of CD14 Gene Is Associated with Adverse Outcome among Patients Suffering from Cardiovascular Disease.

Authors:  Susanne Schulz; Martin Zielske; Sascha Schneider; Britt Hofmann; Hans-Günter Schaller; Axel Schlitt; Stefan Reichert
Journal:  Mediators Inflamm       Date:  2021-07-08       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.